Social Media Ideas for Medgene

Gene Therapy Partners Aim to Enhance Protein Expression

Avenue Biosciences´ machine learning-powered platform engineers and screens signal peptide variants to increase protein secretion from cells. Circio’s circVec technology has demons...

ProBioGen Grants Transgene Additional License for AGE1.CR.pIX Cell Line

ProBioGen’s AGE1.CR.pIX is a stable proliferating avian cell line derived from duck embryo primary cells. It was developed as an alternative to the use of chicken eggs for large-sc...

BaseMap ABE Launched for Off-Target Characterization in Base Editing Therapeutic Development

Unlike prediction-based approaches, Broken String Biosciences says BaseMap ABE generates genome-wide data directly from biologically relevant cells, providing researchers with clea...

With $263M, LifeMine unearths a new drug for organ transplants

Led by serial biotech entrepreneur Greg Verdine, the startup mined fungi genomes to find a safer alternative to the drugs widely used to prevent the body from rejecting transplante...

Labcorp launches DTC ‘Genetic Health Panel’ to seek out multiple diseases

Labcorp is launching the Marker by Labcorp Genetic Health Panel, a new direct-to-consumer genetic testing tool that analyzes 163 genes to determine patients’ risk of over 100 hered...

A genomic-led strategy to anticipate drug safety effects

by Brian R. Ferolito, Andrea R. V. R. Horimoto, Kai Gravel-Pucillo, Daniel J. Golden, Hesam Dashti, Claudia Giambartolomei, Danielle Rasooly, Rachael Matty, Liam Gaziano, Yakov Tse...

StockWatch: Merck/Moderna Cancer Vaccine Gives a Shot in the Arm to Sequencing Companies, Too

Because intismeran autogene is a personalized cancer therapy made for each patient based on the individual genetic mutations of their tumors, the Merck-Moderna stock surge extended...

Scribe records upsized $129M IPO to bankroll lipid-lowering genetic meds

In vivo gene editing outfit Scribe Therapeutics has priced its IPO at $128.7 million, surpassing the $96 million goal set out earlier this week.

Google DeepMind、90億通りの全塩基変異の影響を予測した「AlphaGenome Atlas」　学術向けに無償提供

Google DeepMindは、ヒトゲノムで起こり得る約90億通り全ての一塩基変異の影響を事前予測したデータベース「AlphaGenome Atlas」を公開した。影響度を数値化するスコアも導入し、未解明な非コー...

Andelyn to Support Manufacturing Scaleup for Genprex’s Diabetes Gene Therapy

Under the agreement, Andelyn will transition Genprex's adeno-associated virus (AAV)-based diabetes gene therapy candidate with process optimization, scale-up, and IND-enabling and...

Rznomics Joins Lilly Gateway Labs to Quicken RNA Therapeutic Candidate Discovery and Development

Through its entry into Lilly Gateway Labs, Rznomics officials say they plan to accelerate candidate discovery and development across its target gene database bank comprising over 2...

Ultragenyx Gene Therapy Becomes First FDA-Approved Treatment for Ultra-Rare Disease

Ultragenyx Pharmaceutical’s Genglycos received accelerated FDA approval for glycogen storage disease type Ia, an inherited enzyme deficiency. It’s also the first approved gene ther...

Geron

Geron Anonymous (not verified) Sat, 08/01/2026 - 21:26 field_thread_url https://cafepharma.com/boards/threads/geron.694511/ board name...

Can a cheek swab screen for 7,442 genetic disorders?

SugarStrings says its proprietary machine learning-based crawler identifies novel mutations with 94.89% accuracy, allowing it to analyse genetic data across more diverse population...

Immuneel, Tata Memorial Centre partner to advance cell and gene therapy research

Among the first projects identified under the partnership is a Phase 2 extension study evaluating the safety and efficacy of IMN-003A cell therapy in adult and paediatric patients...

Celonic and Leukocare Collaborate to Support Complex Biologics and Advanced Drug Development

The collaboration brings together Celonic’s expertise in cell line development, drug substance process development, intensified bioprocessing, and GMP manufacturing with Leukocare’...

Cellares and Sonoma Biotherapeutics Agree to Automate Engineered Treg Cell Therapy Manufacturing

Cellares plans to translate the manufacturing of SonomaBio’s SBT-77-7101 onto its Cell Shuttle and automate in-process and release testing through the Cell Q quality control syste...

Repligen: Acquisition To Add Cell Therapy Capabilities

Regenxbio gene therapy refiling plan derailed by FDA hold over spine MRI findings

The FDA has put a clinical hold on Regenxbio’s RGX-121 over asymptomatic spine MRI findings, derailing the biotech’s plans to refile for approval of the once-rejected gene therapy...

MedLife launches Romania’s first fully domestic intestinal microbiome test

Romanian private healthcare provider MedLife has launched an intestinal microbiome test whose sample processing, sequencing and interpretation are performed entirely in Romania, el...

RNAV8 Bio Joins ARPA-H Team to Pioneer Programmable RNA Medicines

The PROPEL program aims to control gene expression through RNA structure, building logic-gated RNA therapies that switch on only where and when intended, without altering the genom...

DANDELION Computational Tool Identifies Previously Unknown Asthma-Related Genes and Pathway

Researchers developed a computational tool that could help to finding genes most directly related to disease, and which in a reported study identified 21 genes related to asthma, m...

NewBiologix and Synastra Join Forces to Advance rAAV Manufacturing for Duchenne Gene Therapy

The collaboration brings together Synastra’s expertise in genomic engineering, AAV vector design, rare-disease gene therapy, and translational development with NewBiologix’s propri...

GeneInsight: Condensing gene set knowledge via language models

by Wee Loong Chin, Kevin Chen, Timo Lassmann Gene set analysis often returns extensive annotations from multiple sources, requiring manual effort to identify coherent biological t...